Pharmaceutical lifecycle management making the most of each and every brand /
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Kaituhi rangatōpū: | |
| Ētahi atu kaituhi: | |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Hoboken, N.J. :
John Wiley & Sons,
c2012.
|
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- pt. A. Lifecycle management business environment
- pt. B. Lifecycle management regulatory and legal environment
- pt. C. Patents and exclusivities
- pt. D. Developmental LCM
- pt. E. Commercial LCM
- pt. F. Biologics and biosimilars
- pt. G. The integrated brand LCM strategy and its implementation
- pt. H. Integrating LCM with portfolio management.